Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
Authors
Keywords
AD pathophysiology, Biomarker concordance, Threshold, Positivity, Preclinical, Early detection, Positron emission tomography, Phosphorylated tau, Biomarker categorization
Journal
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-22
DOI
10.1186/s13195-019-0478-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
- (2018) Renaud La Joie et al. Alzheimers & Dementia
- 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids
- (2017) Christopher C. Rowe et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Stop Alzheimer’s before it starts
- (2017) Eric McDade et al. NATURE
- Small-molecule PET Tracers for Imaging Proteinopathies
- (2017) Chester A. Mathis et al. SEMINARS IN NUCLEAR MEDICINE
- Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
- (2016) Tobias Bittner et al. Alzheimers & Dementia
- Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials
- (2016) Stacie Weninger et al. Alzheimers & Dementia
- Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
- (2016) Antoine Leuzy et al. BRAIN
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
- (2016) Milos D. Ikonomovic et al. Acta Neuropathologica Communications
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
- (2015) William E. Klunk et al. Alzheimers & Dementia
- Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
- (2015) Elizabeth Morris et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- (2015) Sebastian Palmqvist et al. NEUROLOGY
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
- (2015) Jon B. Toledo et al. JAMA Neurology
- Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls
- (2015) Niklas Mattsson et al. JAMA Neurology
- The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2014) José Luis Molinuevo et al. Alzheimers & Dementia
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
- (2012) T. T. Seppala et al. NEUROLOGY
- Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid
- (2011) Stephen D. Weigand et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- High PIB Retention in Alzheimers Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
- (2010) A. Forsberg et al. Current Alzheimer Research
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
- (2009) Timo Grimmer et al. BIOLOGICAL PSYCHIATRY
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding
- (2009) N. Tolboom et al. JOURNAL OF NUCLEAR MEDICINE
- Relationships between biomarkers in aging and dementia
- (2009) W. J. Jagust et al. NEUROLOGY
- PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment
- (2008) J. Koivunen et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started